The Alzheimer’s drug Reminyl (galantamine hydrobromide) could prove fatal to patients with mild cognitive impairment (MCI), according to Ortho-McNeil Neurologics, the company that makes the drug. The warning was issued to healthcare professionals...
The Alzheimer’s drug Reminyl (galantamine hydrobromide) could prove fatal to patients with mild cognitive impairment (MCI), according to Ortho-McNeil Neurologics, the company that makes the drug. The warning was issued to healthcare professionals...